Pascal Chastagner

39PUBLICATIONS
375CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursNeonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jul 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers.

|Jul 01, 2026
Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

|Jan 27, 2026
Phase I/II Study of the PARP Inhibitor Olaparib and Irinotecan in Children and Young Adults with Recurrent/Refractory Malignancies: Arm D of the AcSé-ESMART Trial.

Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff

|Dec 12, 2025
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II Trial.

Juliet C Gray, Rebekah Weston, Cormac Owens

|Oct 04, 2025
Chemo-Immunotherapy Rescue for High-Risk Neuroblastoma Patients With Progressive Disease Before High-Dose Chemotherapy: Real-World Data From the SACHA-France Study.

Claudia Pasqualini, Stéphanie Proust, Gudrun Schleiermacher

|Sep 25, 2025
Outcome of Premature Infants Treated With Chemotherapy for Neuroblastoma in France.

Dana Al Khalifa, Pascal Chastagner, Gudrun Schleiermacher

Pageof 7

Frequent Collaborators

11 joint publications

Gaelle Pierron

9 joint publications

Birgit Geoerger

8 joint publications

Olivier Delattre

7 joint publications

Didier Surdez